{"disease":{"id":"polyvascular-disease","name":"polyvascular disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05189847","title":"Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis","phase":"","overall_status":"COMPLETED","enrollment_count":3059,"lead_sponsor_name":"Eurasian Association of Therapists","has_results":false},{"nct_id":"NCT06231966","title":"Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2462,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06016608","title":"An Imaging Study of Polyvascular Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Harbin Medical University","has_results":false},{"nct_id":"NCT06666101","title":"Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Université Libre de Bruxelles","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}